Esther Redin

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 5

Top Topics

Epidermal Growth Factor Receptor

Small Cell Lung Cancer

Regulatory T Cells

Top Venues

Cancer research

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Francisco Expósito, Miriam Redrado, Maeva Houry, Katherine Hastings, Magdalena Molero, Teresa Lozano, José Luis Solórzano, Julián Sanz, Vera Adradas, Ramon Amat, Esther Redin, Sergio Leon, Naroa Legarra, Javier Garcia, Angel Rodriguez, Karmele Valencia, Camila Robles-Oteíza, Giorgia Foggetti, Nerea Otegui, Enriqueta Felip Font, Juan Jose Lasarte, Luis G Paz-Ares, Jon Zugazagoitia, Katerina Politi, Luis M Montuenga, Alfonso Calvo
PTEN loss confers resistance to anti-PD-1 therapy in non-small cell lung cancer by increasing tumor infiltration of regulatory T cells. Cancer research (2023)
Nerea Otegui, Maeva Houry, Imanol Arozarena, Angel Rodriguez, Esther Redin, Francisco Expósito, Sergio Leon, Karmele Valencia, Luis M Montuenga, Alfonso Calvo
Cancer Cell-Intrinsic Alterations Associated with an Immunosuppressive Tumor Microenvironment and Resistance to Immunotherapy in Lung Cancer. Cancers 15 (12) (2023)
Nerea Otegui, Maeva Houry, Imanol Arozarena, Angel Rodriguez, Esther Redin, Francisco Expósito, Sergio Leon, Karmele Valencia, Luis M Montuenga, Alfonso Calvo
Cancer Cell-Intrinsic Alterations Associated with an Immunosuppressive Tumor Microenvironment and Resistance to Immunotherapy in Lung Cancer. Cancers 15 (12) (2023)
Fernando Torres Andón, Sergio Leon, Aldo Ummarino, Esther Redin, Paola Allavena, Angel Rodriguez, Clément Anfray, Alfonso Calvo
Innate and Adaptive Responses of Intratumoral Immunotherapy with Endosomal Toll-Like Receptor Agonists. Biomedicines 10 (7) (2022)
Irati Garmendia, Esther Redin, Luis M Montuenga, Alfonso Calvo
YES1: A Novel Therapeutic Target and Biomarker in Cancer. Molecular cancer therapeutics 21 (9) (2022)